183 related articles for article (PubMed ID: 21203859)
1. The effect of incident cancer, depression and pulmonary disease exacerbations on type 2 diabetes control.
Bayliss EA; Blatchford PJ; Newcomer SR; Steiner JF; Fairclough DL
J Gen Intern Med; 2011 Jun; 26(6):575-81. PubMed ID: 21203859
[TBL] [Abstract][Full Text] [Related]
2. Tailored or adapted interventions for adults with chronic obstructive pulmonary disease and at least one other long-term condition: a mixed methods review.
Dennett EJ; Janjua S; Stovold E; Harrison SL; McDonnell MJ; Holland AE
Cochrane Database Syst Rev; 2021 Jul; 7(7):CD013384. PubMed ID: 34309831
[TBL] [Abstract][Full Text] [Related]
3. Depression Is Associated with Readmission for Acute Exacerbation of Chronic Obstructive Pulmonary Disease.
Iyer AS; Bhatt SP; Garner JJ; Wells JM; Trevor JL; Patel NM; Kirkpatrick d; Williams JC; Dransfield MT
Ann Am Thorac Soc; 2016 Feb; 13(2):197-203. PubMed ID: 26599286
[TBL] [Abstract][Full Text] [Related]
4. Depression is not associated with diabetes control in minority elderly.
Palta P; Golden SH; Teresi JA; Palmas W; Trief P; Weinstock RS; Shea S; Manly JJ; Luchsinger JA
J Diabetes Complications; 2014; 28(6):798-804. PubMed ID: 25156987
[TBL] [Abstract][Full Text] [Related]
5. Impact of comorbidity type on measures of quality for diabetes care.
Woodard LD; Urech T; Landrum CR; Wang D; Petersen LA
Med Care; 2011 Jun; 49(6):605-10. PubMed ID: 21422952
[TBL] [Abstract][Full Text] [Related]
6. Physical activity and risk of comorbidities in patients with chronic obstructive pulmonary disease: a cohort study.
Yu T; Ter Riet G; Puhan MA; Frei A
NPJ Prim Care Respir Med; 2017 May; 27(1):36. PubMed ID: 28522822
[TBL] [Abstract][Full Text] [Related]
7. Independent contribution of A1C, systolic blood pressure, and LDL cholesterol control to risk of cardiovascular disease hospitalizations in type 2 diabetes: an observational cohort study.
Nichols GA; Joshua-Gotlib S; Parasuraman S
J Gen Intern Med; 2013 May; 28(5):691-7. PubMed ID: 23345072
[TBL] [Abstract][Full Text] [Related]
8. Maintenance of Clinical Endpoints After Discharge from a Pharmacist-Managed Risk Reduction Clinic at a Veterans Affairs Medical Center.
Sherrill CH; Pentecost A; Wood EE
J Manag Care Spec Pharm; 2016 Jan; 22(1):14-20. PubMed ID: 27015047
[TBL] [Abstract][Full Text] [Related]
9. Independent effect of depression and anxiety on chronic obstructive pulmonary disease exacerbations and hospitalizations.
Xu W; Collet JP; Shapiro S; Lin Y; Yang T; Platt RW; Wang C; Bourbeau J
Am J Respir Crit Care Med; 2008 Nov; 178(9):913-20. PubMed ID: 18755925
[TBL] [Abstract][Full Text] [Related]
10. Effect of a Collaborative Care Model on Depressive Symptoms and Glycated Hemoglobin, Blood Pressure, and Serum Cholesterol Among Patients With Depression and Diabetes in India: The INDEPENDENT Randomized Clinical Trial.
Ali MK; Chwastiak L; Poongothai S; Emmert-Fees KMF; Patel SA; Anjana RM; Sagar R; Shankar R; Sridhar GR; Kosuri M; Sosale AR; Sosale B; Rao D; Tandon N; Narayan KMV; Mohan V;
JAMA; 2020 Aug; 324(7):651-662. PubMed ID: 32809002
[TBL] [Abstract][Full Text] [Related]
11. The Association of Depressive Symptoms With Rates of Acute Exacerbations in Patients With COPD: Results From a 3-year Longitudinal Follow-up of the ECLIPSE Cohort.
Yohannes AM; Mülerová H; Lavoie K; Vestbo J; Rennard SI; Wouters E; Hanania NA
J Am Med Dir Assoc; 2017 Nov; 18(11):955-959.e6. PubMed ID: 28733182
[TBL] [Abstract][Full Text] [Related]
12. Association between medicated obstructive pulmonary disease, depression and subjective health: results from the population-based Gutenberg Health Study.
Ghaemi Kerahrodi J; Brähler E; Wiltink J; Michal M; Schulz A; Wild PS; Münzel T; Toenges G; Lackner KJ; Pfeiffer N; Beutel ME
Sci Rep; 2019 Dec; 9(1):20252. PubMed ID: 31882715
[TBL] [Abstract][Full Text] [Related]
13. Associations among chronic obstructive pulmonary disease with asthma, pneumonia, and corticosteroid use in the general population.
Yeh JJ; Lin CL; Kao CH
PLoS One; 2020; 15(2):e0229484. PubMed ID: 32092112
[TBL] [Abstract][Full Text] [Related]
14. A self-management approach using self-initiated action plans for symptoms with ongoing nurse support in patients with Chronic Obstructive Pulmonary Disease (COPD) and comorbidities: the COPE-III study protocol.
Lenferink A; Frith P; van der Valk P; Buckman J; Sladek R; Cafarella P; van der Palen J; Effing T
Contemp Clin Trials; 2013 Sep; 36(1):81-9. PubMed ID: 23770110
[TBL] [Abstract][Full Text] [Related]
15. Exploring the impact of number and type of comorbidities on the risk of severe COPD exacerbations in Korean Population: a Nationwide Cohort Study.
Kim Y; Kim YJ; Kang YM; Cho WK
BMC Pulm Med; 2021 May; 21(1):151. PubMed ID: 33957924
[TBL] [Abstract][Full Text] [Related]
16. Economic burden in direct costs of concomitant chronic obstructive pulmonary disease and asthma in a Medicare Advantage population.
Blanchette CM; Gutierrez B; Ory C; Chang E; Akazawa M
J Manag Care Pharm; 2008 Mar; 14(2):176-85. PubMed ID: 18331119
[TBL] [Abstract][Full Text] [Related]
17. Mortality and Morbidity Effects of Long-Term Exposure to Low-Level PM
Brunekreef B; Strak M; Chen J; Andersen ZJ; Atkinson R; Bauwelinck M; Bellander T; Boutron MC; Brandt J; Carey I; Cesaroni G; Forastiere F; Fecht D; Gulliver J; Hertel O; Hoffmann B; de Hoogh K; Houthuijs D; Hvidtfeldt U; Janssen N; Jorgensen J; Katsouyanni K; Ketzel M; Klompmaker J; Hjertager Krog N; Liu S; Ljungman P; Mehta A; Nagel G; Oftedal B; Pershagen G; Peters A; Raaschou-Nielsen O; Renzi M; Rodopoulou S; Samoli E; Schwarze P; Sigsgaard T; Stafoggia M; Vienneau D; Weinmayr G; Wolf K; Hoek G
Res Rep Health Eff Inst; 2021 Sep; 2021(208):1-127. PubMed ID: 36106702
[TBL] [Abstract][Full Text] [Related]
18. Asthma and Chronic Obstructive Pulmonary Disease Overlap Syndrome: Doubled Costs Compared with Patients with Asthma Alone.
Gerhardsson de Verdier M; Andersson M; Kern DM; Zhou S; Tunceli O
Value Health; 2015 Sep; 18(6):759-66. PubMed ID: 26409602
[TBL] [Abstract][Full Text] [Related]
19. Risk of exacerbation of pulmonary comorbidities in patients with rheumatoid arthritis after initiation of abatacept versus TNF inhibitors: A cohort study.
Kang EH; Jin Y; Desai RJ; Liu J; Sparks JA; Kim SC
Semin Arthritis Rheum; 2020 Jun; 50(3):401-408. PubMed ID: 31813561
[TBL] [Abstract][Full Text] [Related]
20. Risk factors for acute exacerbations of COPD in a primary care population: a retrospective observational cohort study.
Müllerová H; Shukla A; Hawkins A; Quint J
BMJ Open; 2014 Dec; 4(12):e006171. PubMed ID: 25524545
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
